Fresenius Medical Care (NYSE:FMS) Shares Gap Down – Here’s What Happened

Fresenius Medical Care AG (NYSE:FMS)’s share price gapped down prior to trading on Friday . The stock had previously closed at $22.48, but opened at $21.85. Fresenius Medical Care shares last traded at $21.91, with a volume of 23,815 shares trading hands.

Analyst Ratings Changes

A number of research analysts recently weighed in on FMS shares. Berenberg Bank initiated coverage on Fresenius Medical Care in a research note on Wednesday, November 6th. They set a “buy” rating and a $25.60 price target on the stock. Truist Financial boosted their price objective on Fresenius Medical Care from $22.00 to $23.00 and gave the company a “hold” rating in a report on Monday, October 7th. Finally, StockNews.com assumed coverage on Fresenius Medical Care in a report on Thursday. They set a “strong-buy” rating for the company.

Fresenius Medical Care Stock Performance

The stock has a market cap of $12.92 billion, a P/E ratio of 18.20, a P/E/G ratio of 1.03 and a beta of 0.91. The company has a fifty day moving average price of $20.97 and a 200 day moving average price of $20.31. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.37 and a quick ratio of 1.02.

Institutional Investors Weigh In On Fresenius Medical Care

Several institutional investors have recently bought and sold shares of the stock. Allworth Financial LP boosted its position in Fresenius Medical Care by 53.1% in the third quarter. Allworth Financial LP now owns 1,675 shares of the company’s stock worth $36,000 after purchasing an additional 581 shares during the last quarter. Wilmington Savings Fund Society FSB purchased a new position in Fresenius Medical Care in the third quarter worth $38,000. GAMMA Investing LLC boosted its position in Fresenius Medical Care by 50.4% in the third quarter. GAMMA Investing LLC now owns 4,998 shares of the company’s stock worth $106,000 after purchasing an additional 1,675 shares during the last quarter. ORG Wealth Partners LLC purchased a new position in Fresenius Medical Care in the third quarter worth $112,000. Finally, Venturi Wealth Management LLC boosted its position in Fresenius Medical Care by 1,045.8% in the third quarter. Venturi Wealth Management LLC now owns 5,259 shares of the company’s stock worth $112,000 after purchasing an additional 4,800 shares during the last quarter. Institutional investors own 8.25% of the company’s stock.

About Fresenius Medical Care

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.